Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit

por Luo, Xiaobing, Cui, Huijuan, Cai, Lun, Zhu, Wei, Yang, Wei-Chih, Patrick, Michael, Zhu, Shigui, Huang, Jiaqi, Yao, Xin, Yao, Yihong, He, Yukai, Ji, Yun
Publicado 2020

Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma

por Qu, Xiaoyan, An, Gang, Sui, Weiwei, Wang, Tingyu, Zhang, Xian, Yang, Junfang, Zhang, Yan, Zhang, Lu, Zhu, Dan, Huang, Jiaqi, Zhu, Shigui, Yao, Xin, Li, Jing, Zheng, Chengxiao, Zhu, Kevin, Wei, Yutian, Lv, Xiaoteng, Lan, Liping, Yao, Yihong, Zhou, Daobin, Lu, Peihua, Qiu, Lugui, Li, Jianyong
Publicado 2022